Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Xtandi® Capsules 40 mg Protocol for Long-Term Specified Drug Use-Results Survey

NCT02669771 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT02669771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02669771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Xtandi® Capsules 40 mg Protocol for Long-Term Specified Drug Use-Results Survey
Lead sponsor
Astellas Pharma Inc
Phase
Observational
Overall status
Completed
Start date
November 30, 2014
Completion date
November 30, 2018
Enrollment
1,018 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

castration-resistant prostate cancer